Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

I
Iadecola, Sara

Unit of Biostatistics for Clinical Research Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 410) PROTEOMICS ANALYSIS IDENTIFIES A SIGNATURE THAT IMPROVES PROGNOSTIC RISK STRATIFICATION OF THE SARCULATOR NOMOGRAM IN PATIENTS WITH SOFT TISSUE SARCOMAS OF THE EXTREMITIES AND TRUNK WALL
Sara Iadecola
Favorite
Iannarino, Nick

University of Michigan-Dearborn, Department of Language, Culture and the Arts
(P 07) IDENTIFYING CONCERNS OF ADOLESCENT AND YOUNG ADULT SARCOMA PATIENTS AND SURVIVORS FOLLOWING FERTIITY PRESERVATION
Nick Iannarino
Favorite
Ibáñez del Prado, Celia

Complutense University
(P 149) PSYCOLOGICAL SNAPSHOT OF SARCOMA PATIENTS FROM AN ACADEMIC, UNIVERSITY CENTER, HOSPITAL CLÍNICO SAN CARLOS (HCSC), MADRID, A SARCOMA NATIONAL REFERRAL CENTRE IN SPAIN
Celia Ibáñez del Prado
Favorite
Ibanez Sanchez, Glorymar

Memorial Sloan Kettering Cancer Center
(P 289) IDENTIFICATION OF EFFECTIVE THERAPEUTIC COMBINATIONS WITH THE NUCLEAR EXPORT PROTEIN INHIBITOR, SELINEXOR, IN PEDIATRIC SOLID TUMORS
Glorymar Ibanez Sanchez
Favorite
Ibarra, Joe

Ann & Robert H Lurie Children's Hospital of Chicago
(P 365) MULTIMODAL ANALYSIS OF NUCLEAR AND GENOMIC ORGANIZATION IN RHABDOMYOSARCOMA AND NORMAL MYOGENIC CELLS
Joe Ibarra
Favorite
Ibe, Izuchukwu

University of Mississippi
(P 484) OBESITY INCREASES THE RISK OF MAJOR WOUND COMPLICATIONS FOLLOWING PELVIC RESECTION FOR BONE SARCOMA
Izuchukwu Ibe
Favorite
Ibrahim, Mays

Tom Baker Cancer Center
(P 454) TREATMENT PATTERNS AND OUTCOMES IN PEDIATRIC AND ADULT PATIENTS WITH EWING AND UNDIFFERENTIATED ROUND BLUE CELL SARCOMAS IN ALBERTA
Mays Ibrahim
Favorite
Ibrahim, Toni

Istituto Ortopedico Rizzoli IRCCS, Osteoncology- Bone and Soft Tissue Sarcomas and Innovative Therapies Unit, Bologna, Italy
(P 01) EXTRASKELETAL EWING SARCOMA OF THE EXTREMITIES AND TRUNK IN < 25 YEARS OLD PATIENTS: A RETROSPECTIVE ANALYSIS OF A MONO-INSTITUTIONAL SERIES.
Toni Ibrahim
Favorite
(P 253) THE EFFICACY OF MEDICATED PATCHES IN SOFT TISSUE SARCOMAS: IN-VITRO AND EX-VIVO VALIDATION.
Toni Ibrahim
Favorite
(P 283) A TRIDIMENSIONAL PRECLINICAL MODEL TO STUDY HUMAN AND CANINE OSTEOSARCOMA DEVELOPMENT AND INTERACTION WITH TUMOR MICROENVIRONMENT
Toni Ibrahim
Favorite
(P 437) ULTRA-RARE UNDIFFERENTIATED SMALL ROUND CELL SARCOMA: HOW SHOULD WE TREAT THEM? AN ANALYSIS FORM THE GRACEFUL PROJECT
Toni Ibrahim
Favorite
(P 533) SAFETY AND PRELIMINARY BIOLOGICAL ACTIVITY OF A PHASE II TRIAL OF AUTOLOGOUS DENDRITIC CELLS VACCINATION IN SARCOMAS.
Toni Ibrahim
Favorite
Ichikawa, Hitoshi

National Cancer Center Research Institute
(P 76) GENETIC EVIDENCE OF METACHRONOUS DEDIFFERENTIATION OF CHONDROSARCOMA AT A DISTANT SITE
Hitoshi Ichikawa
Favorite
(P 396) COMPREHENSIVE WHOLE-GENOME MOLECULAR PROFILING IN BONE AND SOFT TISSUE SARCOMA: MULTI-OMICS ANALYSIS OF 627 CASES ACROSS HISTOLOGIC SUBTYPES
Hitoshi Ichikawa
Favorite
Ichimura, Masahiko

National Cancer Center Hospital
(P 10) ATEZOLIZUMAB IN JAPANESE PATIENTS WITH ADVANCED ALVEOLAR SOFT PART SARCOMA: A MULTI-CENTER, SINGLE-ARM, INVESTIGATOR-INITIATED PHASE 2 TRIAL (NCCH1907)
Masahiko Ichimura
Favorite
Ignazzi, Gianluca

Italian Sarcoma Group
(P 74) SACRAL CHORDOMA: A RANDOMIZED & OBSERVATIONAL STUDY ON SURGERY VS DEFINITIVE RADIOTHERAPY IN PRIMARY LOCALIZED DISEASE (SACRO). INTERIM ANALYSIS
Gianluca Ignazzi
Favorite
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Gianluca Ignazzi
Favorite
Ijsselsteijn, Marieke

LUMC
(P 368) DECODING THE IMMUNOGENOMIC DETERMINANTS OF RADIOTHERAPY RESPONSE IN SOFT TISSUE SARCOMAS
Marieke Ijsselsteijn
Favorite
Ijzerman, Nikki

Netherlands Cancer Institute/ Antoni van Leeuwenhoek
(P 31) NEOADJUVANT IMATINIB IN LOCALLY ADVANCED GASTROINTESTINAL STROMAL TUMORS (GIST) IS EFFECTIVE AND SAFE: RESULTS FROM A PROSPECTIVE SINGLE CENTER STUDY WITH 108 PATIENTS
Nikki Ijzerman
Favorite
(P 197) PROPRANOLOL MONOTHERAPY IN ANGIOSARCOMA - A WINDOW-OF-OPPORTUNITY STUDY (PROPANGIO)
Nikki Ijzerman
Favorite
Ikegami, Masachika

Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
(P 396) COMPREHENSIVE WHOLE-GENOME MOLECULAR PROFILING IN BONE AND SOFT TISSUE SARCOMA: MULTI-OMICS ANALYSIS OF 627 CASES ACROSS HISTOLOGIC SUBTYPES
Masachika Ikegami
Favorite
Ikegami, Masachika

Division of Cellular Signaling, National Cancer Center Research Institute
(P 406) EXTENSIVE ANALYSIS OF 59 SARCOMA-RELATED FUSION GENES IDENTIFIED PAZOPANIB AS A POTENTIAL INHIBITOR TO COL1A1-PDGFB FUSION GENE
Masachika Ikegami
Favorite
Ikuta, Kunihiro

Nagoya University Hospital
(P 163) SELUMETINIB IN JAPANESE PEDIATRIC PATIENTS WITH SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE 1
Kunihiro Ikuta
Favorite
Ilaslan, Hakan

Cleveland clinic
(P 242) WHOLE BODY PET/MRI FOR STAGING OF MYXOID LIPOSARCOMA
Hakan Ilaslan
Favorite
Imagama, Shiro

Nagoya University Hospital
(P 163) SELUMETINIB IN JAPANESE PEDIATRIC PATIENTS WITH SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE 1
Shiro Imagama
Favorite
Imoto, Seiya

The Institute of Medical Science, The University of Tokyo
(P 396) COMPREHENSIVE WHOLE-GENOME MOLECULAR PROFILING IN BONE AND SOFT TISSUE SARCOMA: MULTI-OMICS ANALYSIS OF 627 CASES ACROSS HISTOLOGIC SUBTYPES
Seiya Imoto
Favorite
Imura, Yoshinori

Osaka University
(P 05) COEFFICIENT OF VARIATION OF T2-WEIGHTED MRI PREDICTS THE PROGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Yoshinori Imura
Favorite
Indelicato, Danny

UFPTI
(P 68) METASTASIS-DIRECTED RADIOTHERAPY FOR EWING SARCOMA PATIENTS ENROLLED ON AEWS1221: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP (COG)
Danny Indelicato
Favorite
(P 81) OPTIMIZING EWING SARCOMA AND OSTEOSARCOMA BIOPSY ACQUISITION: CONSENSUS RECOMMENDATIONS FROM THE CHILDREN'S ONCOLOGY GROUP BONE TUMOR COMMITTEE
Danny Indelicato
Favorite
Ingham, Matthew

Columbia University Medical Center
(P 164) INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY AND IMMUNE ACTIVATION IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Matthew Ingham
Favorite
(P 182) UPDATED RESULTS FROM AN ONGOING PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Matthew Ingham
Favorite
Ingley, Katrina

University College Hospital London (UCLH)
(P 50) CHARACTERIZATION OF A FAMILIAL GIST KINDRED INTOLERANT TO IMATINIB
Katrina Ingley
Favorite
Ingram, Davis

The University of Texas MD Anderson Cancer Center
(P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)
Davis Ingram
Favorite
(P 198) PERSONALIZED MULTIDISCIPLINARY MANAGEMENT OF SARCOMA IN PATIENTS WITH LYNCH SYNDROME
Davis Ingram
Favorite
(P 405) PRIMARY CARDIAC ANGIOSARCOMA- GENOMIC AND MOLECULAR LANDSCAPE
Davis Ingram
Favorite
(P 426) MULTI-OMIC ANALYSIS OF DESMOPLASTIC SMALL ROUND CELL TUMORS REVEAL DISTINCT LINEAGES
Davis Ingram
Favorite
Ingrosso, Matilde

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
(P 144) IMPLEMENTATION OF THE EUROPEAN CLINICAL TRIAL REGULATION: SURVEY OF THE ITALIAN SARCOMA GROUP CENTERS
Matilde Ingrosso
Favorite
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Matilde Ingrosso
Favorite
Inigo, Fatima

Research Institute of the McGill University Health Center
(P 64) OSTEOSARCOMA. PATIENT-DERIVED XENOGRAFTS MODELS TO RECAPITULATE PATIENTS' CHEMORESISTANCE AND METASTATIC DISEASE
Fatima Inigo
Favorite
Innis, Scott

Foghorn Therapeutics
(P 271) PHARMACODYNAMICS AND MECHANISTIC IMPACTS OF FHD-609, A BROMODOMAIN-CONTAINING PROTEIN 9 DEGRADER, IN A PHASE 1 STUDY IN PATIENTS WITH ADVANCED SYNOVIAL SARCOMA OR SMARCB1-LOSS TUMORS
Scott Innis
Favorite
Intini, Giuseppe

University of Pittsburgh
(P 411) A SPATIAL TRANSCRIPTOMIC "GOOGLE MAP" OF HUMAN OSTEOSARCOMA REVEALS COMMON CELL CLUSTERS AT THE PRIMARY SITE AND PULMONARY METASTASES.
Giuseppe Intini
Favorite
Iovino, Anthony

Huntsman Cancer Institute/University of Utah
(P 412) LEIOMYOSARCOMA POLYANEUPLOID CANCER CELLS DEVELOP IN RESPONSE TO CHEMOTHERAPY AND CONTRIBUTE TO CHEMORESISTANCE
Anthony Iovino
Favorite
Ippolito, Joseph

University of Chicago
(P 474) PREDICTORS OF EARLY INTROWTH AND FAILURE FOLLOWING SHORT COMPRESS SPINDLE OSSEOINTEGRATION FIXATION AT THE LOWER EXTREMITIES
Joseph Ippolito
Favorite
(P 475) PRE-PLATING PRIOR TO INTERCALARY TUMOR RESECTION AND ALLOGRAFT RECONSTRUCTION: LESSONS LEARNED
Joseph Ippolito
Favorite
(P 476) FAVORABLE RESULTS FOLLOWING TREATMENT OF UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROGRAFT TECHNIQUE
Joseph Ippolito
Favorite
(P 477) TREATMENT OF PROXIMAL FEMUR UNICAMERAL BONE CYSTS WITH DOXYCYCLINE SCLEROTHERAPY
Joseph Ippolito
Favorite
(P 478) TREATMENT OF CHONDROBLASTOMA WITH PERCUTANEOUS CRYOABLATION
Joseph Ippolito
Favorite
(P 479) EXPANDABLE ENDOPROSTHESES: SHOULD WE CONSIDER NARROWING OUR INDICATIONS? A SYSTEMATIC REVIEW OF THE LITERATURE AND COMPARISON OF OUTCOMES BY AGE GROUPS
Joseph Ippolito
Favorite
(P 480) TARGETED MUSCLE REINNERVATION FOR HIP DISARTICULATION - EVALUATION OF EARLY FUNCTIONAL OUTCOMES
Joseph Ippolito
Favorite
(P 481) CUSTOM ADAPTERS FOR COMPRESS SPINDLE OSSEOINTEGRATION FIXATION IN REVISION LIMB SALVAGE SURGERY OF THE DISTAL FEMUR: A CASE SERIES
Joseph Ippolito
Favorite
Isakoff, Michael

Connecticut Children's Medical Center
(P 81) OPTIMIZING EWING SARCOMA AND OSTEOSARCOMA BIOPSY ACQUISITION: CONSENSUS RECOMMENDATIONS FROM THE CHILDREN'S ONCOLOGY GROUP BONE TUMOR COMMITTEE
Michael Isakoff
Favorite
(P 392) IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT OF OSTEOSARCOMA
Michael Isakoff
Favorite
(P 537) TGFβ IMPRINTED, EX VIVO EXPANDED UNIVERSAL DONOR NATURAL KILLER CELLS WITH CHEMOTHERAPY FOR RELAPSED BONE AND SOFT TISSUE SARCOMA - NCT05634369, REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Michael Isakoff
Favorite
Isella, Claudio

Candiolo Cancer Institute IRCCS FPO
(P 262) ESTABLISHMENT AND CHARACTERIZATION OF THE FIRST RADIATION-INDUCED, PATIENT-DERIVED ANGIOSARCOMA CELL LINE
Claudio Isella
Favorite
Isern Verdu, Josep

Hospital de la Santa Creu i Sant Pau
(P 313) SPACIALLY-FRACTIONATED RADIOTHERAPY (LATTICE) TREATMENT IN INOPERABLE NON-EXTREMITY BULKY SOFT-TISSUE SARCOMAS
Josep Isern Verdu
Favorite
(P 503) SCAPULAR PROSTHESIS RECONSTRUCTION, EXPERIENCE IN OUR INSTITUTION
Josep Isern Verdu
Favorite
(P 504) WHY DO SOME PATIENTS WITH SYNOVIAL SARCOMA HAVE BETTER FUNCTIONAL OUTCOMES AFTER RESECTION SURGERY? ANALYSIS OF 102 CASES
Josep Isern Verdu
Favorite
(P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT
Josep Isern Verdu
Favorite
(P 508) DREAM, UTOPIA OR REALISM? PROGNOSTIC FACTORS IN LUNG METASTASECTOMY OF DISSEMINATED SARCOMA DISEASE
Josep Isern Verdu
Favorite
Ishii, Takeaki

Research Institute of the McGill University Health Center
(P 64) OSTEOSARCOMA. PATIENT-DERIVED XENOGRAFTS MODELS TO RECAPITULATE PATIENTS' CHEMORESISTANCE AND METASTATIC DISEASE
Takeaki Ishii
Favorite
Ishikawa, Koji

Duke University
(P 375) IDENTIFICATION OF METASTATIC CELLS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: SINGLE CELL RNA SEQUENCING AND CIBERSORT ANALYSIS
Koji Ishikawa
Favorite
Isler, Marc

CIUSSS Est-de-l'Île-de-Montréal
(P 134) IMPACT OF THE PARTNERSHIP BETWEEN TERTIARY CENTERS AND NON-SARCOMA RADIOLOGY CENTERS.
Marc Isler
Favorite
Istl, Alexandra

Medical College of Wisconsin
(P 181) REAL-WORLD EXPERIENCE WITH LIPOSOMAL DOXORUBICIN IN METASTATIC AND LOCALLY ADVANCED SARCOMA
Alexandra Istl
Favorite
(P 346) DETECTION OF GERMLINE VARIANTS IN PATIENTS DIAGNOSED WITH SOFT TISSUE SARCOMA USING EXPANDED
Alexandra Istl
Favorite
(P 473) GROIN PAINS: APPROACHES AND OUTCOMES FOR INGUINOFEMORAL SOFT TISSUE SARCOMAS
Alexandra Istl
Favorite
Italiano, Antoine

Institut Bergonié
(P 135) UNMET NEEDS IN LOCALLY ADVANCED (UNRESECTABLE) OR METASTATIC DEDIFFERENTIATED LIPOSARCOMA AND EXPECTATIONS FOR CLINICAL TRIALS: AN INTERNATIONAL DELPHI CONSENSUS STUDY
Antoine Italiano
Favorite
(P 300) ANTI-TUMOR ACTIVITY OF PARP7 INHIBITOR RBN-2397 IN SOFT-TISSUE SARCOMAS
Antoine Italiano
Favorite
(P 418) GENOMIC AND IMMUNOLOGICAL PROFILING OF PRIMARY AND DISTANT METASTASES OF SOFT TISSUE SARCOMAS
Antoine Italiano
Favorite
(P 437) ULTRA-RARE UNDIFFERENTIATED SMALL ROUND CELL SARCOMA: HOW SHOULD WE TREAT THEM? AN ANALYSIS FORM THE GRACEFUL PROJECT
Antoine Italiano
Favorite
(P 523) IN-BETWEEN SARCOMA: A CATEGORY OF HIGH RISK OF RECURRENCE AND POOR OUTCOME
Antoine Italiano
Favorite
Iuliani, Michele

Università Campus Bio-Medico di Roma
(P 263) HER2 AS A POTENTIAL NOVEL THERAPEUTIC TARGET IN SOFT TISSUE SARCOMAS
Michele Iuliani
Favorite
(P 264) CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS AND TRABECTEDIN IN SOFT TISSUE SARCOMA: A NOVEL POTENTIAL SYNERGY?
Michele Iuliani
Favorite
Ivanescu, Cristina

IQVIA
(P 188) IMPACT OF NIROGACESTAT ON FUNCTIONAL STATUS IN PATIENTS WITH DESMOID TUMORS: RESULTS FROM THE PHASE 3 DEFI STUDY
Cristina Ivanescu
Favorite
Iwata, Shintaro

National Cancer Center Hospital
(P 80) OPTIMIZING DOSE OF MAP THERAPY FOR CHILDREN, YOUNG ADULTS AND ADULTS WITH OSTEOSARCOMA; A SINGLE-CENTRE RETROSPECTIVE ANALYSIS
Shintaro Iwata
Favorite
(P 152) EVALUATING DIAGNOSTIC APPROACHES TO DERMATOFIBROSARCOMA PROTUBERANS: AN OPPORTUNITY TO REDUCE THE NUMBER OF INTERVENTIONS
Shintaro Iwata
Favorite
(P 332) SURGICAL OUTCOMES OF RETROPERITONEAL LIPOSARCOMA - SINGLE INSTITUTIONAL STUDY N JAPAN -
Shintaro Iwata
Favorite
(P 342) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
Shintaro Iwata
Favorite
Iyer, Gopa

Memorial Sloan Kettering Cancer Center
(P 540) PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 AND TSC2 (PRECISION I)
Gopa Iyer
Favorite